![]() |
Ovarian Neoplasms |
Free Subscription
1 Am J Obstet Gynecol |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Ovarian Neoplasms is free of charge.
Uptake and patient-related outcomes of mainstreaming genetic testing: a
systematic review and meta-analysis.
Am J Obstet Gynecol. 2025;233:276-291.
PubMed
Abstract available
Isoform-level analyses of 6 cancers uncover extensive genetic risk mechanisms
undetected at the gene-level.
Br J Cancer. 2025;133:874-885.
PubMed
Abstract available
Eur J Obstet Gynecol Reprod Biol
Niraparib combined with anlotinib after PARPi resistance in ovarian cancer: A
single-center retrospective study from China.
Eur J Obstet Gynecol Reprod Biol. 2025;314:114707.
PubMed
Abstract available
The role of cytokines in ovarian cancer drug resistance.
Int J Cancer. 2025 Sep 19. doi: 10.1002/ijc.70099.
PubMed
Abstract available
PPT1 is a negative regulator of STING signaling in cancer cells and its
inhibition reactivates immune surveillance in cold tumors.
Proc Natl Acad Sci U S A. 2025;122:e2514948122.
PubMed
Abstract available
Triple checkpoint blockade of PD-1, Tim-3, and Lag-3 enhances adoptive T cell
immunotherapy in a mouse model of ovarian cancer.
Proc Natl Acad Sci U S A. 2025;122:e2419888122.
PubMed
Abstract available
Osteopontin-c gene expression and subcellular localization in ovarian cancer
cells: Implications for prognosis and therapeutic responses.
Tumour Biol. 2025;47:14230380251375818.
PubMed
Abstract available
Thank you for your interest in scientific medicine.